SKN | SPAC Hennessy Capital VIII Prices Upsized $210 Million US IPO Targeting Industrial Innovation
Hennessy Capital VIII Expands IPO Beyond Initial Target
Hennessy Capital Investment VIII, a blank check company sponsored by Hennessy Capital, has priced an upsized U.S....
SKN | Immuno-Responsive Cancer Biotech Eikon Therapeutics Prices Upsized IPO at $18 High End, Signaling Renewed Institutional Appetite for Oncology Listings
Eikon Therapeutics has priced its initial public offering at $18 per share, the top end of its marketed range, in an upsized deal that...
SKN | Colombier Acquisition III Prices $260 Million SPAC IPO Backed by High-Profile Conservative Investors
Lead Paragraph
Colombier Acquisition III has priced its $260 million initial public offering, marking the third SPAC launched by investor Omeed Malik and executives tied...
SKN | ArcelorMittal Holds Near Multi-Year Highs Ahead of Q4 Earnings
ArcelorMittal S.A. shares traded near multi-year highs ahead of the steelmaker’s fourth-quarter 2025 earnings report scheduled for February 5, as investors weigh strong recent...
SKN | Itaú Unibanco Shares Hold Near Multi-Year Highs as Earnings Loom
Shares of Itaú Unibanco Holding S.A. were little changed in recent trading, hovering around $8.80–$8.90, near the upper end of their 52-week range. The...
